Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, MAY 29-31, 2020
-
2020 (v1)Journal articleUploaded on: December 3, 2022
-
2018 (v1)Journal article
Background: Epidermal growth factor receptor (EGFR) gene alterations and amplification are frequently reported in cases of glioblastoma (GBM). However, EGFR-activating mutations that confer proven sensitivity to tyrosine kinase inhibitors (TKIs) in lung cancer have not yet been reported in GBM. Case presentation: Using next-generation...
Uploaded on: December 3, 2022 -
August 2019 (v1)Journal article
BACKGROUND:Response Evaluation Criteria in Solid Tumors (RECIST) are used to assess tumour shrinkage after cytotoxic chemotherapy, but may be inadequate for efficacy evaluation of anti-angiogenic therapies.AIMS:This study aimed to identify novel radiologic tumour response criteria based on early changes in tumour size and density, observed on...
Uploaded on: December 4, 2022 -
November 2008 (v1)Journal article
Tumors that progress do so via their ability to escape the antitumor immune response through several mechanisms, including developing ways to induce the differentiation and/or recruitment of CD4(+)CD25(+) Tregs. The Tregs, in turn, inhibit the cytotoxic function of T cells and NK cells, but whether they have an effect on the cytotoxic function...
Uploaded on: December 3, 2022 -
2016 (v1)Journal article
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, JUN 03-07, 2016
Uploaded on: December 3, 2022 -
October 18, 2017 (v1)Conference paper
Many researches have been conducted in the last decades on the determination of the minimal clinically important difference(MCID) for health-related quality of life (HRQOL) scores. Several methods have been proposed, generally classified in distribution oranchor-based methods. A joint use of both distribution and anchorbased approaches, using...
Uploaded on: December 3, 2022 -
July 2017 (v1)Journal article
International audience
Uploaded on: February 28, 2023 -
August 2016 (v1)Journal article
Glioblastoma is the most common malignant brain tumor in adults. Baseline health‐related quality of life (HRQoL) is a major subject of concern for these patients. We aimed to assess the independent prognostic value of HRQoL in unresectable glioblastoma (UGB) patients for death risk stratification. One hundred and thirty‐four patients with UGB...
Uploaded on: December 4, 2022